Schedule +


Monday 21st | Tuesday 22nd May

Screen Shot 2018-05-09 at 17.43.56.png

Monday 2 1 . 0 5 . 2 0 1 8
6.30 - 9.30pm : Welcome Drinks
kindly sponsored by MedReleaf

Join us at the beautiful Nobu Hotel in Shoreditch for drinks, networking and to toast the inaugural Cannabis Europa.

Tuesday 2 2 . 0 5 . 2 0 1 8
9am - 6pm : Full Day Conference
kindly sponsored by Canaccord Genuity, Scythian Biosciences and Phytoplant Research

Lively talks and discussions featuring a range of European and international experts. Focus is on problem solving uniquely European medical cannabis issues.

Tuesday 2 2 . 0 5 . 2 0 1 8
12.40 - 1.40pm : Networking Lunch
kindly sponsored by 420 Advisory Management

The Networking lunch is served in the Barbican Garden Room.

Tuesday 2 2 . 0 5 . 2 0 1 8
6 - 9pm : Post-Conference Drinks Reception
kindly sponsored by Spectrum Cannabis

Evening drinks are served in the spectacular Barbican Conservatory.

Topic Tracks


Keynote +
In Conversation

the passion & stories behind the biggest news & companies in medical cannabis


British Life Science Innovation on World Stage

Former UK Life Sciences Minister, George Freeman MP, talks with Michael Abbott, CEO of Columbia Care, about his journey from London policeman to medical cannabis entrepreneur.

The Growth of a Global Cannabis Health Company

Bruce Linton, CEO of Canopy Growth Corporation talks value and expansion with Iain Martin, Editor of Reaction, columnist at the Times and author of Crash, Bang, Wallop.

Crossing Paths: Medical Cannabis Journeys

DJ and activist Chelsea Leyland talks advocacy with champions of compassion and care Carola Perez & Tom Curran.


Science + Medicine
+ Public Health

The ups & downs of research, The public concerns & Medical education


Promise and Pitfalls: Medical Cannabis and Public Health

Prof Harry Sumnall of the Public Health Institute, Brendan Hughes of the EMCDDA and Chandni Hindocha of UCL's Clinical Psychopharmacology Unit discuss what public health could gain from medical cannabis, and what regulators should be wary of, with Dr Henry Fisher, partner at Hanway Associates.

Medical Application: Caring with Cannabis

Medical cannabis can be used for over 40 conditions but how can we provide accurate and reliable patient care? Genevieve Edwards from the MS Society, Na'ama Saban of Tikun Olam, Jacqueline Poitras from MAMAKA and Florian Rister of Hanfverband meet Clark French, Head of the United Patients Alliance, to understand the problems faced by cannabis patients.

Under the Microscope: Medical Cannabis Discoveries

What next for cannabinoid therapeutics? Gregor Zorn, co-founder of ECTA, hears from Dr Cristina Sánchez of Complutense University, Madrid, Dr Arno Hazekamp of Hazekamp Herbal Consulting and Dr Saoirse O'Sullivan of the University of Nottingham as they highlight the most promising cannabinoid research to emerge in the test tube and the clinic.

Ensuring Best Practice and Quality

How to standardise a plant? Stefan Meyer, Dr Shane Morris, Dr Markus Roggen and Sébastien Béguerie join Iñaki García to discuss the challenges of making consistent, reliable medicines from the cannabis plant, and why quality is key.

Teaching Cannabis Treatments

How can we close the gap between policy and application? Dr Lorenzo Calvi from the University of Pavia, Dr Marco Ternelli from Farmagalenica and Dr Ife Abiola of 420 Advisory Management join Professor Mike Barnes to discuss how education will be instrumental to the success of medical cannabis in Europe.

What Modern Medical Cannabis Looks Like

In an ideal world, how should cannabinoids be formulated and delivered for maximum therapeutic effect? Jessica Steinberg hears from Philippe Rogueda, Dr Andrew Loxley and Dr Monica Vialpando as they divine the future of medical cannabis products.


Policy + Politics
+ The Media

Brave policy & good government: 
the processes behind medical cannabis


Continental Policies: Governing Across Borders

Ian Dunt hears from Estefanía Torres Martínez MEP, Stelios Kouloglou MEP and Prof. Guglielmo Trovato of the EMA on the prospects for EU-wide regulation of medical cannabis products

Innovating Around a Bureaucracy

Will bureaucracy aid or impede cannabis reform? Crispin Blunt MP, Jeff Smith MP, Miles Briggs MSP and Blair Gibbs, former government advisor, meet Tim Colbourne, Director of Policy at Open Reason, to investigate the convoluted processes around cannabis legislation.

Mobilising Opinion: Can We Change Cannabis Policies?

Polly MacKenzie of Demos talks to Sarah Bain, VP of External Affairs at Nesta, Steve Moore, director of Volteface, Sam Hall, Head of Research at Bright Blue, and Ian Birrell, Contributing Editor of the Mail on Sunday, grapple with the thorny issue of how to change cannabis laws and policies.

Actioning Change in a Diverse Region

Andrea Lijertwood hosts Alfredo Pascual of Transnational Cannabis Consultancy, Mike Dacks of MedReleaf, João Taborda da Gama of ASG and Dan Rowland of 420 Advisory Management in order to examine the regulatory issues around cannabis policy implementation.


Business + Data

The companies & Entrepreneurs shaping medical cannabis


Building Businesses and Communities

The cannabis industry is opening up multiple markets for entrepreneurs. Saul Kaye, CEO of iCan, Derek Riedle, CEO of Civilized and Giadha Aguirre de Carcer, CEO of New Frontier Data, speak to George McBride, Partner at Hanway Associates, about building successful businesses which support the medical cannabis industry.

Disruption and Opportunity

Roy Bingham of BDS Analytics, Shane McGuill and Spiros Malandrakis of Euromonitor join Stephen Murphy, Managing Director of Prohibition Partners, to explore the burgeoning commercial opportunity in Europe.

Can Europe Work Together?

Liam McGreevy, of Elite Healthcare Distribution and Ethnopharm, chairs a panel including George Scorsis of Liberty Health Sciences, Tjalling Erkelens of Bedrocan and Ma'ayan Weisberg of Tikun Olam as they debate what the European infrastructure for medical cannabis will look like.

The Harvest: Agriculture and Cannabis

Medical cannabis in Europe is hindered by the lack of local supply. Sébastien Béguerie, founder of AlphaCat Labs, hears from Dan Sutton of Tantalus Labs, Gianpaolo Grassi of CREA-CIN and Dave Pryce of Canopy Growth on the state of play in European cannabis cultivation.

Investment in the European Medical Cannabis Industry

Cannabis investments have gone from beyond the pale to de rigeur in a few short years. Scythian CEO, Rob Reid, hosts Lorne Gertner of Tokyo Smoke, Neil Maruoka of Canaccord, Kfir Kachlon of OurCrowd, and Stephen Rockman of Merism Capital to discuss how investing in the medical cannabis industry is undergoing dramatic transformations..